)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
IRLAB Therapeutics (IRLAB) investor relations material
IRLAB Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary29 Oct, 2025
Executive summary
Submitted clinical trial application for IRL757 in Parkinson's disease and apathy to EMA; patient recruitment expected by end of 2025; received additional $4 million for IRL757 study from MSRD.
Rights issue completed, raising SEK 115.7 million, providing capital for IRL1117 and pirepemat development.
New patent for mesdopetam granted in China, securing market exclusivity in major markets until mid-2040s.
Gustaf Albert appointed as new CFO, effective November 17.
Financial highlights
Cash and cash equivalents at period end: SEK 110.1 million (Q3 2025), up from SEK 90.4 million year-over-year.
Net sales for Jan–Sep 2025: SEK 42.7 million, down from SEK 51.8 million year-over-year.
Operating loss for Jan–Sep 2025: SEK -71.5 million, nearly flat year-over-year.
Earnings per share before and after dilution: SEK -1.42 (vs. SEK -1.50 prior year).
R&D costs: SEK 99.8 million, representing 83% of total operating expenses.
Outlook and guidance
Focus on advancing IRL757 study, maintaining cost control, and retaining organizational competence.
Phase Ib study for IRL757 expected to begin patient recruitment by end of 2025, pending EMA approval.
Key milestones in next 12-18 months: Mesdopetam Phase III initiation, Pirepemat dose optimization, IRL757 Phase Ib start, and Phase I readiness for IRL942 and IRL1117.
Ongoing efforts to secure out-licensing or partnership for mesdopetam.
How long does current capital last given burn rate?
How will pirepemat dosing be optimized for Phase III?
What are the next steps for mesdopetam partnering?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next IRLAB Therapeutics earnings date
Q4 202511 Feb, 2026
Next IRLAB Therapeutics earnings date
Q4 202511 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
IRLAB Therapeutics AB is a research and development company developing drugs for the treatment of Parkinson's disease. IRLAB develops drugs that can stop or slow down the loss of neurons in the substantia nigra, where dopamine is produced. In Parkinson's disease, loss of these neurons leads to a gradual degeneration of the motor functions. These drugs will improve symptoms without dramatically increasing the risk of side effects.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage